Anti-fibrotic agents (e.g., Pirfenidone, Nintedanib)

Treatment for Silicosis

Effectiveness
25%
Safety Score
35%
Clinical Trials
4
Participants
80

Comparative Safety Scale(Higher is safer)

Cyanide☠️
MethπŸ’€
Cigarettes🚬
Chemo☒️
Alcohol🍺
MorphineπŸ’Š
AntibioticsπŸ’‰
TylenolπŸ’Š
ExerciseπŸƒ
WaterπŸ’§
35
DangerousModerateSafe
Treatment Details
0
Anti-fibrotic agents (e.g., Pirfenidone, Nintedanib) Outcomes

for Silicosis

Efficacy Outcomes
Overall Effectiveness
+25%

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
No active trials currently recruiting for this treatment

No active trials found in ClinicalTrials.gov